Search

everythinglearnresearchcommunity

for

Search:↓

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

High androgen levels cause skin issues in PCOS, affecting quality of life.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Androgenetic alopecia is significantly linked to metabolic syndrome.

The treatment might help COVID-19 related hair loss, but more research is needed.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

LC-OCT can help diagnose different types of scarring alopecia.

Autoimmune markers may help diagnose and manage PCOS.

High-frequency ultrasound can effectively visualize and assess hair loss.

CGF from platelets helps hair regrowth in people with androgenetic alopecia.

Platelet-Rich Plasma (PRP) treatment can significantly increase hair count and thickness in people with Androgenetic Alopecia (AGA) with minimal side effects.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.

Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.